WallStreetZenWallStreetZen

NASDAQ: FOLD
Amicus Therapeutics Inc Stock Ownership - Who owns Amicus Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Amicus Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Bradley L. CampbellPresident and CEO2026-03-0222,500$14.35
$322.83kSell
Bradley L. CampbellPresident and CEO2026-01-2075,000$6.10
$457.50kBuy
Bradley L. CampbellPresident and CEO2026-01-2075,000$14.31
$1.07MSell
David Michael ClarkChief People Officer2026-01-0318,498$14.27
$263.97kSell
Jeff CastelliChief Development Officer2026-01-0323,102$14.27
$329.67kSell
Ellen RosenbergChief Legal Officer2026-01-0329,683$14.27
$423.58kSell
Samantha ProutChief Accounting Officer2026-01-0312,240$14.27
$174.66kSell
Jeff CastelliChief Development Officer2026-01-026,905$14.27
$98.53kSell
David Michael ClarkChief People Officer2026-01-025,381$14.27
$76.79kSell
Samantha ProutChief Accounting Officer2026-01-023,443$14.27
$49.13kSell

1 of 4

FOLD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FOLD insiders and whales buy or sell their stock.

FOLD Shareholders

What type of owners hold Amicus Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC11.79%37,018,271$531.95MInsider
Blackrock Inc10.36%32,524,381$467.38MInstitution
Vanguard Group Inc9.46%29,702,696$426.83MInstitution
Hbk Investments L P4.86%15,250,000$219.14MInstitution
State Street Corp4.72%14,833,314$213.15MInstitution
Redmile Group LLC4.11%12,890,146$185.23MInsider
Pentwater Capital Management LP3.66%11,500,000$165.26MInstitution
Peter J. Barris3.50%10,982,416$157.82MInsider
C. Richard Kramlich3.50%10,982,416$157.82MInsider
Mark W. Perry3.50%10,982,416$157.82MInsider

1 of 3

FOLD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FOLD66.65%33.35%Net SellingNet Selling
TGTX58.12%41.88%Net Selling
XENE97.14%2.86%Net SellingNet Selling
SRRK60.19%39.81%Net BuyingNet Selling
CRSP68.98%31.02%Net BuyingNet Selling
View Top Biotech Stocks

Amicus Therapeutics Stock Ownership FAQ

Who owns Amicus Therapeutics?

Amicus Therapeutics (NASDAQ: FOLD) is owned by 102.17% institutional shareholders, 51.13% Amicus Therapeutics insiders, and 0.00% retail investors. Perceptive Advisors LLC is the largest individual Amicus Therapeutics shareholder, owning 37.02M shares representing 11.79% of the company. Perceptive Advisors LLC's Amicus Therapeutics shares are currently valued at $531.95M.

If you're new to stock investing, here's how to buy Amicus Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.